Health Populi January 6, 2025
Jane Sarasohn-Kahn

CES 2025: as you read the acronym and year, your brain registered an image like consumer technology and the start of a new year, or some variation of those thoughts.

When you saw the title of this post with the acronym “GLP-1,” your brain might not have connected the dots between a medicine and “CE,” consumer electronics.

But here we are in real-time, in real life, at the convergence of pharmaceuticals and medicines and consumer-facing technology. And keep in mind that we’re at the annual meeting of CES which is convened by the Consumer Technology Association, CTA.

GLP-1s are showing up at #CES2025 in many ways. Here’s what I’m seeing on the ground, in press releases, and in emailed invitations...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Biotechnology, Conferences / Podcast, Pharma / Biotech, Trends
Which Biopharma Startups Made the Cut for INVEST Pitch Perfect?
CAR T-Cell Pioneer Plots Technology’s Next Steps
Eli Lilly Adds Alzheimer’s Care to Digital Health Platform Services
GLP-1 drug use for weight loss has soared, costing billions
GLP-1 spending hits $5.8B for adults without diabetes

Share This Article